Pharmacokinetics, pharmacodynamics, safety and tolerability of 4 weeks' treatment with empagliflozin in Japanese patients with type 2 diabetes mellitus

por Kanada, Shigeto, Koiwai, Kazuki, Taniguchi, Atsushi, Sarashina, Akiko, Seman, Leo, Woerle, Hans J
Publicado 2013

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus

por Heise, Tim, Seman, Leo, Macha, Sreeraj, Jones, Peter, Marquart, Alexandra, Pinnetti, Sabine, Woerle, Hans J., Dugi, Klaus
Publicado 2013

Heart failure documentation in outpatients with diabetes and volume overload: an observational cohort study from the Diabetes Collaborative Registry

por Arnold, Suzanne V., Jones, Philip G., Beasley, Michael, Cordova, Jeanine, Goyal, Abhinav, Fonarow, Gregg C., Seman, Leo
Publicado 2020